Lung cancer

Patent Granted PROBLEM TO BE SOLVED: To provide prognosis testing method, etc. for patients with lung cancer which clarifies the work of esRAGE in vivo, while utilizing its measurements. ; SOLUTION: This post-operative prognosis testing method for the patients with lung cancer, which includes measuring of the amount of manifestation endogenous secretory RAGE (Endogenous Secretory Receptor for Advanced Glycation End products: esRAGE), a test kit used for the above method, a prognosis testing reagent for the patients with lung cancer comprising anti-esRAGE antibody, etc.